-
Bionomics Limited (BNOX) Announces Successful End-of-Phase 2 Meeting with the FDA
-
Bionomics Limited (BNOX) Initiates AFFIRM-1 Phase 3 Trial
-
Bionomics Limited (BNOX) Files for 20.23M Share Offering by Selling Stockholders
-
H.C. Wainwright Reiterates Buy Rating on Bionomics (BNOX), 'positioned well for further positive clinical data readouts'

